1. Home
  2. UFPT vs ABCL Comparison

UFPT vs ABCL Comparison

Compare UFPT & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UFP Technologies Inc.

UFPT

UFP Technologies Inc.

HOLD

Current Price

$255.48

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$6.89

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFPT
ABCL
Founded
1963
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
UFPT
ABCL
Price
$255.48
$6.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$289.00
$8.40
AVG Volume (30 Days)
147.1K
6.5M
Earning Date
05-01-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
15.44
10.91
EPS
2.24
N/A
Revenue
$602,797,000.00
$75,128,000.00
Revenue This Year
$8.12
N/A
Revenue Next Year
$5.72
$21.85
P/E Ratio
$112.83
N/A
Revenue Growth
19.50
160.56
52 Week Low
$173.86
$2.75
52 Week High
$274.93
$6.86

Technical Indicators

Market Signals
Indicator
UFPT
ABCL
Relative Strength Index (RSI) 71.73 70.07
Support Level $205.96 $3.27
Resistance Level $270.31 N/A
Average True Range (ATR) 9.57 0.47
MACD 1.89 0.11
Stochastic Oscillator 97.01 96.95

Price Performance

Historical Comparison
UFPT
ABCL

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: